Pharmacists warn drug shortage affecting cancer patients

Pharmacists have warned that "one of the worst" examples of medicine shortages is affecting cancer patients.

Creon, a pancreatic enzyme replacement therapy (Pert), helps digestion and is required by patients with pancreatic cancer, cystic fibrosis, and chronic pancreatitis. It is thought more than 61,000 patients in the UK need the medicine.

Some patients are said to be "skipping meals" to ration their medication due to a shortage of it, according to the National Pharmacy Association (NPA).

A Department of Health and Social Care spokesperson said there were "European-wide supply issues" and it was "working closely with industry and the NHS" to mitigate the impact on patients.

Without the drug, patients lose weight and strength, which means their ability to cope with treatment such as chemotherapy is reduced.

Some experts have predicted shortages continuing until next year.

The Department of Health and Social Care has extended a serious shortage protocol for Creon which has already been in place for a year.

This indicates concern about shortages of a medicine and allows pharmacists to give patients an alternative - though they argue other drugs are also in short supply.

A spokesperson for the department said the "European-wide supply issues" were caused by manufacturing supply constraints.

Read full story

Source: BBC News, 2 June 2025

Related reading on the hub:

• Medication supply issues: A pharmacist’s perspective
• Medicines shortages: minimising the impact on patients